Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
350
Sort by:
Philippines Orphan Drugs Market Size, Share, Trends and Forecast by Drug Type, Disease Type, Phase, Top Selling Drugs, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The Philippines orphan drugs market size reached USD 1.2 Billion in 2025. Looking forward, the market is expected to reach USD 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 8.17% during 2026...
July 2026
122 pages
Philippines Vaccine Market Size, Share, Trends and Forecast by Technology, Patient Type, Indication, Route Of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The Philippines vaccine market size reached USD 294.8 Million in 2025. Looking forward, the market is projected to reach USD 621.3 Million by 2034, exhibiting a growth rate (CAGR) of 8.38% during 2026...
July 2026
121 pages
Turkey Vaccine Market Size, Share, Trends and Forecast by Technology, Patient Type, Indication, Route of Administration, Product Type, Treatment Type, End User, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The Turkey vaccine market size reached USD 847.9 Million in 2025. The market is projected to reach USD 1,788.3 Million by 2034, exhibiting a growth rate (CAGR) of 8.39% during 2026-2034. The market is...
July 2026
118 pages
Europe GLP-1 / Weight Loss Drugs Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others) and Forecast 2026–2035
US$ 3,840.00
Europe GLP-1 / Weight Loss Drugs Market was valued at USD $1.57 billion in 2026 and is projected to reach USD $16.65 billion by 2035, registering a CAGR of 30.0% across the forecast period. The Europe...
July 2026
379 pages
United States GLP-1 / Weight Loss Drugs Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others) and Forecast 2026–2035
US$ 4,760.00
United States GLP-1 / Weight Loss Drugs Market was valued at USD $350 million in 2026 and is projected to reach USD $4.26 billion by 2035, registering a CAGR of 32.0% across the forecast period. The U...
July 2026
427 pages
U.S. Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Bioanalysis & DMPK studies, Toxicology Testing, Compound Management), By Development Stage, By Indication, By Model Type, By End-use, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The U.S. preclinical CRO market size was valued at USD 1.7 billion in 2025 and is projected to grow from USD 1.8 billion in 2026 to USD 3.1 billion by 2033, at a CAGR of 7.7% from 2026 to 2033. The ma...
July 2026
120 pages
GLP-1 / Weight Loss Drugs Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others), By Region (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America) and Regional Forecast 2026–2035
US$ 4,740.00
GLP-1 / Weight Loss Drugs Market was valued at USD $4.00 billion in 2026 and is projected to reach USD $48.67 billion by 2035, registering a CAGR of 32.0% across the forecast period. The GLP-1 / Weigh...
June 2026
430 pages
Africa Vaccine Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others) and Forecast 2026–2035
US$ 3,840.00
Africa Vaccine Market was valued at USD $250 million in 2026 and is projected to reach USD $690 million by 2035, registering a CAGR of 12.0% across the forecast period. The Africa Vaccine Market conti...
April 2026
445 pages
Contract Research Organization (CRO) Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others), By Region (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America) and Regional Forecast 2026–2035
US$ 4,010.00
Contract Research Organization (CRO) Market was valued at USD $4.50 billion in 2026 and is projected to reach USD $11.51 billion by 2035, registering a CAGR of 11.0% across the forecast period. The Co...
April 2026
388 pages
Orphan Drugs / Rare Disease Therapeutics Market Size, Share, and Analysis, By Product Type (Instruments, Reagents & Consumables, Software & Services), By Application (Clinical Diagnostics, Drug Discovery & Development, Patient Monitoring, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotech Companies, Others), By Region (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America) and Regional Forecast 2026–2035
US$ 3,650.00
Orphan Drugs / Rare Disease Therapeutics Market was valued at USD $180 million in 2026 and is projected to reach USD $540 million by 2035, registering a CAGR of 13.0% across the forecast period. The O...
March 2026
371 pages
Mid-Size Pharmaceutical Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription, Over the Counter), Drug Development Type (In-house and Outsource), Drug Designation Type (Orphan Drugs and Non-Orphan Drugs), Formulation (Tablets and Capsules, Injectables, Topical, and Others), Indication (Cardiovascular Diseases, Pain Management, Respiratory Diseases, Diabetes, Oncology, Infectious Diseases, Neurology, Immunology, Ophthalmology, Autoimmune, and Others), and Geography
US$ 4,450.00
According to our new research study on “Mid-Size Pharmaceutical Market Forecast to 2034 Global Analysis – by technology, application, animal type and Geography,” the market is anticipated to grow from...
July 2024
186 pages
